Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- SHIELDIndependent statistical analysis of Phase III Study in Refractory Behcet's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00995709).
- SHIELD-4Independent statistical analysis of An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SHIFTIndependent statistical analysis of Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study: primary endpoint results,…
- Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: Complete Statistical AnalysisIndependent statistical analysis of Shift-and-persist and Cardiometabolic Markers Among Women in Puerto Rico: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06250738).
- Shifting Rehabilitation Paradigms in Skilled Nursing Facilities: Complete Statistical AnalysisIndependent statistical analysis of Shifting Rehabilitation Paradigms in Skilled Nursing Facilities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02927171).
- Shifting Salty Taste Preferences in Children: Complete Statistical AnalysisIndependent statistical analysis of Shifting Salty Taste Preferences in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02909764).
- Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection: Complete Statistical AnalysisIndependent statistical analysis of Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SHINEIndependent statistical analysis of A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SHINEIndependent statistical analysis of Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- SHINEIndependent statistical analysis of Randomized Controlled Clinical Trial of Weight Loss Programs in Obese Persons: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SHiPIndependent statistical analysis of Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: Complete Statistical AnalysisIndependent statistical analysis of SHO-SAIKO-TO for Patients With Chronic Hepatitis C: A Phase II Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi: Complete Statistical AnalysisIndependent statistical analysis of ShockPulse-SE vs. Trilogy Trial: Comparing the Performance of Two Intracorporeal Lithotripters for Removal of Large Renal Calculi: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Lithoplasty® Study (Disrupt CAD II): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03328949).
- Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): Complete Statistical AnalysisIndependent statistical analysis of Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02650128).
- SHoPPERIndependent statistical analysis of Study of Household Purchasing Patterns, Eating and Recreation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02073643).
- ShOReIndependent statistical analysis of OPT-302 With Ranibizumab in Neovascular Age-related Macular Degeneration (nAMD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04757610).
- Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: Complete Statistical AnalysisIndependent statistical analysis of Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Short Term Follow-up of a Botulinum Toxin Intervention in Children With Spastic Cerebral Palsy: Complete Statistical AnalysisIndependent statistical analysis of Short Term Follow-up of a Botulinum Toxin Intervention in Children With Spastic Cerebral Palsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators: Complete Statistical AnalysisIndependent statistical analysis of Short-term Cardiovascular Benefits of Wearing Particulate-filtering Respirators: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02238028).
- Short-term Effects of Leptin in People With Lipodystrophy: Complete Statistical AnalysisIndependent statistical analysis of Short-term Effects of Leptin in People With Lipodystrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01778556).
- Short-term Health Effects of Wild Blueberry Juice Consumption: Complete Statistical AnalysisIndependent statistical analysis of Short-term Health Effects of Wild Blueberry Juice Consumption: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02139878).
- Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD): Complete Statistical AnalysisIndependent statistical analysis of Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Short-Term Symptom Changes in Adults With Teeth Clenching or Grinding and Jaw Symptoms Receiving Splint, Botulinum Toxin, or Medication Plus Splint Care: Complete Statistical AnalysisIndependent statistical analysis of Short-Term Symptom Changes in Adults With Teeth Clenching or Grinding and Jaw Symptoms Receiving Splint, Botulinum Toxin, or Medication Plus Splint Care: primary endpoint results, effect estimate with…
- Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections: Complete Statistical AnalysisIndependent statistical analysis of Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00466817).
- SHOTIndependent statistical analysis of Screening for Hesitancy to Optimize Talk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02708745).
- Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?: Complete Statistical AnalysisIndependent statistical analysis of Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00509197).
- Shrinking the Size of the Tobacco Power Wall: Complete Statistical AnalysisIndependent statistical analysis of Shrinking the Size of the Tobacco Power Wall: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04632030).
- SHyNIndependent statistical analysis of Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05419830).
- SIBO-PDIndependent statistical analysis of Treating Bacterial Overgrowth in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02470780).
- SICAS-1Independent statistical analysis of Allergens in Inner-City Schools and Childhood Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01756391).
- Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Sick-Day Protocol to Improve Outcomes in Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03141905).
- SICOG 0109Independent statistical analysis of Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives: Complete Statistical AnalysisIndependent statistical analysis of Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00775190).
- Side-OutIndependent statistical analysis of Pilot Study Using Molecular Profiling to Find Potential Targets & Select Treatments for Pts With Met br ca: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SIERRAIndependent statistical analysis of A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate: primary endpoint results, effect estimate with confidence interval,…
- SiFALDIndependent statistical analysis of Role of Sildenafil for Fontan Associated Liver Disease (SiFALD) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03154476).
- SIGMARTIndependent statistical analysis of Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable Angina: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sign Here: How to Conduct Informed Consent With Deaf Individuals: Complete Statistical AnalysisIndependent statistical analysis of Sign Here: How to Conduct Informed Consent With Deaf Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05268055).
- SIGNATUREIndependent statistical analysis of LDE225 for Patients With PTCH1 or SMO Mutated Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02002689).
- SIGNATUREIndependent statistical analysis of MEK162 for Patients With RAS/RAF/MEK Activated Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01885195).
- SIGNATUREIndependent statistical analysis of Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Sildenafil Exercise: Role of PDE5 Inhibition: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil Exercise: Role of PDE5 Inhibition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04039087).
- Sildenafil for Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil for Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00104637).
- Sildenafil for the Treatment of Lymphatic Malformations: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil for the Treatment of Lymphatic Malformations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02335242).
- Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil in HFpEF (Heart Failure With Preserved Ejection Fraction) and PH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Sildenafil Treatment for Mild TBI: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil Treatment for Mild TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03598140).
- Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium: Complete Statistical AnalysisIndependent statistical analysis of Sildenafil Vaginal Gel Co-treatment With Clomiphene Citrate in Infertile Women With Thin Endometrium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SILDI-SAFEIndependent statistical analysis of Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04447989).